These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27756613)

  • 21. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pancreatic juice cytology and/or endoscopic ultrasound-guided fine-needle aspiration biopsy for pancreatic tumor.
    Matsumoto K; Takeda Y; Harada K; Horie Y; Yashima K; Murawaki Y
    J Gastroenterol Hepatol; 2014 Jan; 29(1):223-7. PubMed ID: 23869654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonprevention of post-endoscopic retrograde cholangiopancreatographic pancreatitis by pancreatic stent after aspiration of pure pancreatic juice in patients with intraductal papillary mucinous neoplasms of the pancreas.
    Harada R; Kawamoto H; Fukatsu H; Kato H; Hirao K; Kurihara N; Mizuno O; Ogawa T; Ishida E; Okada H; Yamamoto K; Yamamoto H
    Pancreas; 2010 Apr; 39(3):340-4. PubMed ID: 19823100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
    Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
    Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of pancreatic juice cytology by using synthetic secretin in the diagnosis of pancreatic ductal adenocarcinoma.
    Takeda Y; Matsumoto K; Kurumi H; Koda H; Yamashita T; Onoyama T; Kawata S; Horie Y; Isomoto H
    Dig Endosc; 2018 Nov; 30(6):771-776. PubMed ID: 29873113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Pancreatic Juice Cytology with Synthetic Secretin in Diagnosing Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Takeda Y; Matsumoto K; Onoyama T; Yamashita T; Koda H; Hamamoto W; Sakamoto Y; Shimosaka T; Kawahara S; Horie Y; Isomoto H
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic juice cytology for diagnosing invasive pancreatic carcinoma/high-grade pancreatic intraepithelial neoplasia without visible tumors on endoscopic ultrasound.
    Sagami R; Mizukami K; Nishikiori H; Sato T; Fujiwara S; Kawamoto Y; Ome Y; Honda G; Horiguchi SI; Sato K; Murakami K
    Pancreatology; 2024 Aug; 24(5):740-746. PubMed ID: 38926041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
    Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should we regard all main duct type intraductal papillary mucinous neoplasms of the pancreas (MD-IPMN) as an indication of surgery? -A retrospective study in 29 patients with MD-IPMN showing mural nodules.
    Masaki Y; Koshita S; Noda Y; Kanno Y; Ogawa T; Masu K; Sawai T; Ito K
    Pancreatology; 2019 Mar; 19(2):352-359. PubMed ID: 30679137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
    Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
    Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.
    Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Takasawa O; Akaishi S; Tsuchiya T; Kobari M
    J Gastroenterol; 2005 Jul; 40(7):744-51. PubMed ID: 16082592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules.
    Ohno E; Hirooka Y; Itoh A; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H
    Ann Surg; 2009 Apr; 249(4):628-34. PubMed ID: 19300203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas.
    Eguchi H; Ishikawa O; Ohigashi H; Sasaki Y; Yamada T; Nakaizumi A; Uehara H; Takenaka A; Kasugai T; Imaoka S
    Cancer; 2006 Dec; 107(11):2567-75. PubMed ID: 17054109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural courses of branch duct intraductal papillary mucinous neoplasm.
    Lee T; Kim HJ; Park SK; Yang HJ; Jung YS; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Choi KY
    Langenbecks Arch Surg; 2017 May; 402(3):429-437. PubMed ID: 28255733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Ohtsuka T; Kono H; Nagayoshi Y; Mori Y; Tsutsumi K; Sadakari Y; Takahata S; Morimatsu K; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
    Surgery; 2012 Jan; 151(1):76-83. PubMed ID: 21875733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.